As reported in the worldwide edition of the German journal Angewandte Chemie.

Fenical's group in the Scripps Center for Marine Biotechnology and Biomedicine, working in conjunction with San Diego-based Trius Therapeutics, used an analytical technique referred to as spectroscopy to decipher the unusual framework of a molecule from a microscopic species known as Streptomyces. Initial tests of the compound, which they named anthracimycin, revealed its potency as a killer of anthrax, the infectious disease frequently feared as a biological weapon, in addition to MRSA.Clinton to announce 5-year initiative to slice pollutants; Plan could have positive general public health impact Secretary of Condition Hillary Rodham Clinton is set to announce on Thursday morning a five-year initiative among the U.S. Related StoriesNew WHO guidelines advise lowering sugar intakeCancer medical diagnosis improvements in England: an interview with Lucy Elliss-BrookesDeaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHMEClinton will be became a member of by U.S.